Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes

被引:92
|
作者
Li, W. [1 ,5 ]
Liu, Y. [1 ]
He, Y. -Q. [2 ]
Zhang, J. -W. [1 ]
Gao, Y. [3 ]
Ge, G. -B. [1 ,5 ]
Liu, H. -X. [1 ,5 ]
Huo, H. [1 ]
Liu, H. -T. [1 ,5 ]
Wang, L. -M. [3 ]
Sun, J. [3 ]
Wang, Q. [4 ]
Yang, L. [1 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China
[4] Dalian Univ Technol, Dalian, Peoples R China
[5] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Triptolide; cytochrome P450; mono-hydroxylated metabolite;
D O I
10.1080/00498250802503359
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triptolide, the primary active component of a traditional Chinese medicine Tripterygium wilfordii Hook F, has a wide range of pharmacological activities. In the present study, the metabolism of triptolide by cytochrome P450s was investigated in human and rat liver microsomes. Triptolide was converted to four metabolites (M-1, M-2, M-3, and M-4) in rat liver microsomes and three (M-2, M-3, and M-4) in human liver microsomes. All the products were identified as mono-hydroxylated triptolides by liquid chromatography-mass spectrometry (LC-MS). The studies with chemical selective inhibitors, complementary DNA-expressed human cytochrome P450s, correlation analysis, and enzyme kinetics were also conducted. The results demonstrate that CYP3A4 and CYP2C19 could be involved in the metabolism of triptolide in human liver, and that CYP3A4 was the primary isoform responsible for its hydroxylation.
引用
收藏
页码:1551 / 1565
页数:15
相关论文
共 50 条
  • [1] METABOLIC STABILITY AND CYTOCHROME P450 PHENOTYPING OF TRIPTOLIDE IN HUMAN AND RAT LIVER MICROSOMES
    Li, Wei
    Hu, Zhuohan
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2008, 40 : 27 - 27
  • [2] Characterization of cytochrome p450 involved in the metabolism of ipriflavone in human liver microsomes
    Ji, Hye Young
    Kim, Hui Hyun
    Kim, Young Hoon
    Kim, Soon Ai
    Lee, Hye Suk
    DRUG METABOLISM REVIEWS, 2006, 38 : 47 - 47
  • [3] Nefiracetam hydroxylation by rat liver microsomes and expressed human cytochrome P450s
    Fujimaki, Y
    Hakusui, H
    Yamazoe, Y
    XENOBIOTICA, 1996, 26 (08) : 821 - 830
  • [4] Inhibition of cytochrome P450 by ethambutol in human liver microsomes
    Lee, Sang Yoon
    Jang, Himchan
    Lee, Ji-Yoon
    Kwon, Kwang-Il
    Oh, Soo Jin
    Kim, Sang Kyum
    TOXICOLOGY LETTERS, 2014, 229 (01) : 33 - 40
  • [5] Inhibition of cytochrome P450 by propolis in human liver microsomes
    Ryu C.S.
    Oh S.J.
    Oh J.M.
    Lee J.-Y.
    Lee S.Y.
    Chae J.-W.
    Kwon K.-I.
    Kim S.K.
    Toxicological Research, 2016, 32 (3) : 207 - 213
  • [6] Metabolism of Sesamin by Cytochrome P450 in Human Liver Microsomes
    Yasuda, Kaori
    Ikushiro, Shinichi
    Kamakura, Masaki
    Ohta, Miho
    Sakaki, Toshiyuki
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (12) : 2117 - 2123
  • [7] Hydroxylation of liquiritigenin in human liver microsomes is specifically catalyzed by cytochrome P450 1A2
    Liu, Hui-Xin
    Hu, Ying
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2009, 41 : 150 - 151
  • [8] Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes
    Yoshii, K
    Kobayashi, K
    Tsumuji, M
    Tani, M
    Shimada, N
    Chiba, K
    LIFE SCIENCES, 2000, 67 (02) : 175 - 184
  • [9] Inhibition of Magnolol and Honokiol on Cytochrome P450 Enzymes in Rat and Human Liver Microsomes
    Jin Duan
    Juan Xiao
    Yong Chen
    Feng-mei Han
    Chinese Herbal Medicines, 2015, 7 (02) : 167 - 172
  • [10] Inhibition of Magnolol and Honokiol on Cytochrome P450 Enzymes in Rat and Human Liver Microsomes
    Duan, Jin
    Xiao, Juan
    Chen, Yong
    Han, Feng-mei
    CHINESE HERBAL MEDICINES, 2015, 7 (02) : 167 - 172